Director, US Market Access Analytics
Revolution Medicines is a global, commercial-state oncology company dedicated to discovering, developing and delivering innovative medicines for patients with RAS-addicted cancers. Leveraging its differentiated RAS(ON) tri-complex inhibitor platform, the company is advancing a broad, integrated portfolio of oral RAS(ON) inhibitors designed to directly target the active, cancer-driving state of RAS. Founded on rigorous scientific inquiry and a willingness to challenge long-held assumptions, Revolution Medicines is committed to changing the trajectory of disease for patients with RAS-addicted cancers worldwide.
Our people are united by a shared way of working: follow the science, challenge assumptions, act with urgency and hold ourselves to a high standard of rigor—all in service of patients.
The Opportunity:
Reporting directly to the Vice President, US Analytics & Insights, the Director, Market Access Analytics will serve as the analytics and insights leader dedicated to US Market Access. This role will support launch planning and commercialization readiness by translating payer, reimbursement, contracting, channel, and patient access data into clear strategic guidance for the organization.
Candidates should bring deep knowledge of the US market access landscape, strong analytical and business-p
